Equities analysts expect that NNN Healthcare/Office REIT Inc (NYSE:HTA) will announce sales of $176.40 million for the current fiscal quarter, according to Zacks. Five analysts have provided estimates for NNN Healthcare/Office REIT’s earnings, with the lowest sales estimate coming in at $174.30 million and the highest estimate coming in at $177.90 million. NNN Healthcare/Office REIT posted sales of $139.88 million during the same quarter last year, which would indicate a positive year over year growth rate of 26.1%. The business is scheduled to issue its next earnings report on Monday, July 30th.
According to Zacks, analysts expect that NNN Healthcare/Office REIT will report full-year sales of $709.35 million for the current fiscal year, with estimates ranging from $700.97 million to $718.30 million. For the next financial year, analysts forecast that the firm will post sales of $737.28 million per share, with estimates ranging from $716.28 million to $758.30 million. Zacks Investment Research’s sales averages are an average based on a survey of analysts that follow NNN Healthcare/Office REIT.
Get NNN Healthcare/Office REIT alerts:NNN Healthcare/Office REIT (NYSE:HTA) last issued its earnings results on Monday, April 30th. The real estate investment trust reported $0.05 earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of $0.42 by ($0.37). NNN Healthcare/Office REIT had a return on equity of 1.82% and a net margin of 9.04%. The firm had revenue of $175.60 million for the quarter, compared to analysts’ expectations of $175.17 million. During the same quarter in the previous year, the firm posted $0.41 EPS. The firm’s revenue for the quarter was up 41.3% compared to the same quarter last year.
A number of analysts have recently issued reports on HTA shares. Zacks Investment Research upgraded NNN Healthcare/Office REIT from a “sell” rating to a “hold” rating in a report on Wednesday, April 25th. Jefferies Group reiterated a “buy” rating and set a $32.00 target price on shares of NNN Healthcare/Office REIT in a report on Monday, March 26th. Morgan Stanley decreased their target price on NNN Healthcare/Office REIT from $33.00 to $30.00 and set an “overweight” rating for the company in a report on Tuesday, March 20th. Stifel Nicolaus decreased their target price on NNN Healthcare/Office REIT from $35.00 to $32.00 and set a “hold” rating for the company in a report on Friday, February 16th. Finally, BMO Capital Markets set a $31.00 target price on NNN Healthcare/Office REIT and gave the stock a “buy” rating in a report on Monday, March 26th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company. The company presently has an average rating of “Hold” and a consensus target price of $31.82.
In other NNN Healthcare/Office REIT news, CEO Scott D. Peters sold 77,425 shares of the company’s stock in a transaction that occurred on Monday, April 9th. The stock was sold at an average price of $26.28, for a total value of $2,034,729.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.90% of the stock is owned by corporate insiders.
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Kempen Capital Management N.V. boosted its holdings in NNN Healthcare/Office REIT by 66.0% in the 1st quarter. Kempen Capital Management N.V. now owns 452,165 shares of the real estate investment trust’s stock worth $11,960,000 after acquiring an additional 179,795 shares during the period. Principal Financial Group Inc. boosted its holdings in NNN Healthcare/Office REIT by 6.2% in the 1st quarter. Principal Financial Group Inc. now owns 4,107,229 shares of the real estate investment trust’s stock worth $108,636,000 after acquiring an additional 241,551 shares during the period. Xact Kapitalforvaltning AB boosted its holdings in NNN Healthcare/Office REIT by 67.0% in the 1st quarter. Xact Kapitalforvaltning AB now owns 22,683 shares of the real estate investment trust’s stock worth $600,000 after acquiring an additional 9,100 shares during the period. Royal Bank of Canada boosted its holdings in NNN Healthcare/Office REIT by 5.4% in the 1st quarter. Royal Bank of Canada now owns 4,938,837 shares of the real estate investment trust’s stock worth $130,631,000 after acquiring an additional 251,499 shares during the period. Finally, McKinley Carter Wealth Services Inc. purchased a new position in NNN Healthcare/Office REIT in the 1st quarter worth approximately $120,000. Hedge funds and other institutional investors own 98.67% of the company’s stock.
Shares of NYSE:HTA traded up $0.33 during trading on Wednesday, reaching $24.78. 1,453,780 shares of the stock were exchanged, compared to its average volume of 1,467,850. The company has a debt-to-equity ratio of 0.84, a quick ratio of 1.51 and a current ratio of 1.51. NNN Healthcare/Office REIT has a 12-month low of $24.06 and a 12-month high of $32.83. The stock has a market capitalization of $5.05 billion, a P/E ratio of 15.20, a PEG ratio of 3.66 and a beta of 0.20.
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 10th. Shareholders of record on Thursday, July 5th will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a yield of 4.92%. The ex-dividend date is Tuesday, July 3rd. NNN Healthcare/Office REIT’s dividend payout ratio is presently 74.85%.
NNN Healthcare/Office REIT Company Profile
Healthcare Trust of America, Inc (NYSE: HTA) is the largest dedicated owner and operator of medical office buildings ("MOBs") in the United States based on gross leasable area ("GLA"). We provide the real estate infrastructure for the integrated delivery of healthcare services in highly desirable locations.
Get a free copy of the Zacks research report on NNN Healthcare/Office REIT (HTA)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
No comments:
Post a Comment